Inflammatory Pseudotumor Involving the Skull Base: Response to Steroid and Radiation Therapy

2006 ◽  
Vol 135 (1) ◽  
pp. 144-148 ◽  
Author(s):  
Dong Kyung Lee ◽  
Yang-Sun Cho ◽  
Sung Hwa Hong ◽  
Won Ho Chung ◽  
Yong Chan Ahn
2012 ◽  
Vol 138 (8) ◽  
pp. 765 ◽  
Author(s):  
Wilson B. Chwang ◽  
Ruchika Jain ◽  
Ananth Narayan ◽  
Jonathan McHugh ◽  
Tamer Ghanem ◽  
...  

2014 ◽  
Vol 125 (4) ◽  
pp. 813-821 ◽  
Author(s):  
Stuti V. Desai ◽  
Eleonora F. Spinazzi ◽  
Christina H. Fang ◽  
Grace Huang ◽  
Senja Tomovic ◽  
...  

2021 ◽  
pp. 1-2
Author(s):  
A. Bazine ◽  
M. Torreis ◽  
M. Elmarjany ◽  
M. Benlemlih ◽  
A. Maghous ◽  
...  

Multiple myeloma (MM) is typically characterized by neoplastic proliferation of plasma cells in the bone marrow and can result in extensive skeletal destruction. Involvement of skull base is extremely rare, especially sphenoid bone. We report in this work the case of a 62-year-old woman, who presented with a sphenoid relapse of multiple myeloma treated with radiation therapy, with signicant clinical improvement and almost complete disappearance of the sphenoid metastasis. We shed light, through this case, on the rarity of sphenoid metastases in multiple myeloma and on the role of radiotherapy in the management of this type of location.


1988 ◽  
Vol 98 (2) ◽  
pp. 150-154 ◽  
Author(s):  
Mitchell K. Schwaber ◽  
Gerald S. Gussack ◽  
Wanda Kirkpatrick

The major source of controversy that surrounds the use of radiation for glomus tumors is the finding of persistent chief cells years after completion of the treatment. Questions have been raised as to the viability of the irradiated chief cell and its capacity to proliferate. The radiotherapists consider a stable glomus tumor a radiation “cure,” whereas skull base surgeons are fearful that these lesions will continue to slowly grow and cause problems 20 to 30 years later. We have recently managed a patient who was not a candidate for surgery, with a catecholamine-secreting glomus jugulare tumor. after 4750 rad of radiation therapy, no changes in tumor size or in catecholamine secretion have been observed (at 20 months of followup). The implications of the case are discussed.


Sign in / Sign up

Export Citation Format

Share Document